Laboratory monitoring of low-molecular-weight heparin therapy--part II. Monitoring LMWH therapy? For the moment a non-question

J Thromb Haemost. 2005 Mar;3(3):571-3. doi: 10.1111/j.1538-7836.2005.01206.x.
No abstract available

MeSH terms

  • Blood Coagulation / drug effects
  • Drug Monitoring / methods*
  • Heparin, Low-Molecular-Weight / pharmacokinetics*
  • Humans
  • Partial Thromboplastin Time
  • Thrombin / antagonists & inhibitors

Substances

  • Heparin, Low-Molecular-Weight
  • Thrombin